Related references
Note: Only part of the references are listed.ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update
Sofia Ramiro et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis
Casper Webers et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
Augusta Ortolan et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
Management of Axial Disease in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
Ennio Lubrano et al.
JOURNAL OF RHEUMATOLOGY (2023)
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial
Jeffrey R. Curtis et al.
ANNALS OF THE RHEUMATIC DISEASES (2023)
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
Steven R. Ytterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Choose wisely: imaging for diagnosis of axial spondyloarthritis
Torsten Diekhoff et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group
Xenofon Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Early identification of axial psoriatic arthritis among patients with psoriasis: a prospective multicentre study
Fabian Proft et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Atul Deodhar et al.
LANCET (2022)
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
Laura C. Coates et al.
NATURE REVIEWS RHEUMATOLOGY (2022)
Efficacy and safety of guselkumab in biologic-naive patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial
Dafna D. Gladman et al.
TRIALS (2022)
A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis
Peter C. Taylor et al.
JOURNAL OF RHEUMATOLOGY (2021)
Efficacy of tofacitinib in reduction of inflammation detected on MRI in patients with Psoriatic ArthritiS presenTing with axial involvement (PASTOR): protocol of a randomised, double-blind, placebo-controlled, multicentre trial
Fabian Proft et al.
BMJ OPEN (2021)
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
Atul Deodhar et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Clinical features of psoriatic arthritis
Mitsumasa Kishimoto et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2021)
Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies
Philip J Mease et al.
Lancet Rheumatology (2021)
Axial Disease in Psoriatic arthritis: The presence and progression of unilateral grade 2 sacroiliitis in a psoriatic arthritis cohort
Joy Feld et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
Axial involvement in psoriatic arthritis: An update for rheumatologists
Denis Poddubnyy et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
Denis Poddubnyy et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2021)
Frequency of MRI changes suggestive of axial spondyloarthritis in the axial skeleton in a large population-based cohort of individuals aged <45 years
Xenofon Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Axial disease in psoriatic arthritis
Philip S. Helliwell
RHEUMATOLOGY (2020)
Frequencies of musculoskeletal symptoms and disorders in the population-based German National Cohort (GNC)
Carsten Oliver Schmidt et al.
BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2020)
Clinical and imaging characteristics of osteitis condensans ilii as compared with axial spondyloarthritis
Denis Poddubnyy et al.
RHEUMATOLOGY (2020)
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Laure Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naive active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials
Philip S. Helliwell et al.
RMD OPEN (2020)
What constitutes the fat signal detected by MRI in the spine of patients with ankylosing spondylitis? A prospective study based on biopsies obtained during planned spinal osteotomy to correct hyperkyphosis or spinal stenosis
Xenofon Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Psoriatic spondylitis or ankylosing spondylitis with psoriasis: same or different?
Vinod Chandran
CURRENT OPINION IN RHEUMATOLOGY (2019)
MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group
Walter P. Maksymowych et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis
Joachim Sieper et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis
Atul Deodhar et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
Desiree van der Heijde et al.
LANCET (2019)
Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
Philip J. Mease et al.
JOURNAL OF RHEUMATOLOGY (2018)
Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison
Joy Feld et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
Dominique Baeten et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care
Denis Poddubnyy et al.
RMD OPEN (2018)
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis
Deepak R. Jadon et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis?
Lihi Eder et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
The critical role of interleukin-23 in spondyloarthropathy
Jonathan P. Sherlock et al.
MOLECULAR IMMUNOLOGY (2014)
Magnetic Resonance Imaging Assessment of Axial Psoriatic Arthritis: Extent of Disease Relates to HLA-B27
Concepcion Castillo-Gallego et al.
ARTHRITIS AND RHEUMATISM (2013)
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis
Ilaria Tinazzi et al.
RHEUMATOLOGY (2012)
Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study
I-H Song et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Polymorphism 4g/5g of the PAI-1 Gene and Atherosclerosis Detection Using Carotid Ultrasound in Patients with Systemic Lupus Erythematosus
B. Cepeda et al.
JOURNAL OF RHEUMATOLOGY (2011)
Risk Factors for Axial Inflammatory Arthritis in Patients with Psoriatic Arthritis
Vinod Chandran et al.
JOURNAL OF RHEUMATOLOGY (2010)
Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS)
D. D. Gladman et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Axial Psoriatic Arthritis: Update on a Longterm Prospective Study
Vinod Chandran et al.
JOURNAL OF RHEUMATOLOGY (2009)
Clinical assessment of sacroiliitis and HLA-B27 are poor predictors of sacroiliitis diagnosed by magnetic resonance imaging in psoriatic arthritis
L Williamson et al.
RHEUMATOLOGY (2004)